AJMC® in the Press, August 23, 2024

The Emerging Landscape of GLP-1 RA Therapies Across Conditions

Tezepelumab (Tezspire) improves symptoms, reduces surgery needs, and lowers steroid use in patients with chronic rhinosinusitis with nasal polyps (CRSwNP).

October 14th 2025

Medicare Expenditures in the First Year of Amyotrophic Lateral Sclerosis Diagnosis

The founder and President of Phesi addresses the need for streamlining clinical trial data as GLP-1 RA therapies are being used to treat multiple diseases.

Listen

How Medicaid Reforms Could Deepen State Coverage Gaps

Medicare expenditures for patients with amyotrophic lateral sclerosis are more than 3 times those of the average Medicare beneficiary, and drug therapies are an important cost driver.

Square Podcast Managed Care Cast AJMC_Podcast

October 7th 2025

Reduction in Food Allergies Found After Guideline-Directed Early Peanut Exposure

Laxmi Patel of Savista discusses how the Budget Reconciliation Act could widen Medicaid coverage gaps and strain hospitals across states.

Listen

Peanuts | Image credit: amstockphoto - stock.adobe.com

Long-Term Data for PHAROS Show Half of Treatment-Naïve Patients Receiving Encorafenib Plus Binimetinib Alive at 4 Years

Guidelines that encouraged the exposure of peanuts in children were found to significantly reduce food allergies.

Tezepelumab Becomes First TSLP-Targeting Biologic Approved by FDA for CRSwNP

A mini oral session at ESMO of targeted therapy in non-small cell lung cancer included treatments that showed effectiveness in brain metastases.

Related Content

The Emerging Landscape of GLP-1 RA Therapies Across Conditions

Tezepelumab (Tezspire) improves symptoms, reduces surgery needs, and lowers steroid use in patients with chronic rhinosinusitis with nasal polyps (CRSwNP).

October 14th 2025

Medicare Expenditures in the First Year of Amyotrophic Lateral Sclerosis Diagnosis

The founder and President of Phesi addresses the need for streamlining clinical trial data as GLP-1 RA therapies are being used to treat multiple diseases.

Listen

How Medicaid Reforms Could Deepen State Coverage Gaps

Medicare expenditures for patients with amyotrophic lateral sclerosis are more than 3 times those of the average Medicare beneficiary, and drug therapies are an important cost driver.

October 7th 2025

Reduction in Food Allergies Found After Guideline-Directed Early Peanut Exposure

Laxmi Patel of Savista discusses how the Budget Reconciliation Act could widen Medicaid coverage gaps and strain hospitals across states.

Listen

Long-Term Data for PHAROS Show Half of Treatment-Naïve Patients Receiving Encorafenib Plus Binimetinib Alive at 4 Years

Guidelines that encouraged the exposure of peanuts in children were found to significantly reduce food allergies.